The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.
about
Self-report measures of medication adherence behavior: recommendations on optimal useContemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative reviewUnderstanding the role of mHealth and other media interventions for behavior change to enhance child survival and development in low- and middle-income countries: an evidence reviewAzvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitroMAHILA: a protocol for evaluating a nurse-delivered mHealth intervention for women with HIV and psychosocial risk factors in IndiaAdherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice.Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Associations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America.Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.A counselor in your pocket: feasibility of mobile health tailored messages to support HIV medication adherence.Prospective State and Trait Predictors of Daily Medication Adherence Behavior in HIV.The impact of cognitive function on medication management: three studies.Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study.Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trialStrategies for promoting adherence to antiretroviral therapy: a review of the literatureImproving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendationsHow long is the right interval for assessing antiretroviral pharmacy refill adherence?Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherenceFrom access to engagement: measuring retention in outpatient HIV clinical care.Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya.Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherenceValidating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South AfricaAdherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR.A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trialEffect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.Predictors of adherence to glaucoma treatment in a multisite study.Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participantsEffect of a modified saquinavir/ritonavir dosing regimen with lower dose lead-in phase on QTc interval, pharmacokinetics, antiviral activity and safety in treatment-naïve HIV-1-infected patientsPharmacists' strategies for promoting medication adherence among patients with HIV.Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failureComprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected childrenThe impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohortCould caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa.Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.Comparing different measures of retention in outpatient HIV care.Survival functions for defining a clinical management Lost To Follow-Up (LTFU) cut-off in Antiretroviral Therapy (ART) program in Zomba, Malawi.Adherence to antiretroviral therapy among HIV-infected adults in the United States.The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa.Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
P2860
Q26775742-39FB5D1E-B50A-4D5E-AEF6-09814EA9BB9DQ26783160-CCCADFAC-27FD-45B8-9C4E-846194D72A8FQ26830628-FE486EFC-C5FF-403D-85FF-0204A5CABF62Q28542490-003F6B96-4DA7-4B97-951C-B9F62C05C984Q28598268-61B0DAD1-F8D1-4D2E-A430-A10287D217EBQ30409638-2D70C469-B557-40BF-89A0-D28F2839C393Q30558310-7227E168-F746-4F90-BF7E-2E3BC6B52781Q31125998-B376C737-AB18-4F9E-ABAB-D4F7099463A8Q33393729-FDBC7135-DF1B-4CAA-B498-0481AB7C299CQ33445540-0F74CAC0-9DF4-40EF-9563-3E0A643B9780Q33455270-A595A140-9EDA-464C-B795-EE49D59FEDD5Q33596657-C04693E6-0525-4B66-AD2A-7BBA2A4B61FCQ33699710-E4829E20-95C4-4FA4-B8A8-503768B3C15EQ33713856-8A32E1C9-53BA-4D4F-A18E-033004B12459Q33764003-DCB70F54-861E-4082-990C-3E3A9F5FF596Q33787619-D79D6CAC-DC0E-4482-AAE5-D1057088DF6CQ34157887-21D33EA1-2B0E-47E7-88AF-0B831819E941Q34188261-E6DD188A-8C5D-4D0C-8902-E4EB411ADB97Q34249254-9D2A6205-DACC-47CE-9D06-02FC107D9D6CQ34577449-D7F466D7-E10F-45B0-8CF0-2B951C80562BQ34603715-3F9D8F0A-19C5-4C7A-B129-272BDE4A2BCCQ34624904-D329DB01-0838-418D-BE6A-91E3F8F62B95Q34786563-69B1B59B-7470-459C-8F09-E708986332C3Q34792200-06AA58E0-4C78-4452-8DEE-986F44CF2073Q35001897-F780766A-CECB-4CCD-B649-4160EA75ACA8Q35108156-6D48F3DA-2872-48B5-A0EB-0B6737A21A5EQ35156644-FDE8F8B8-5057-4F93-A646-A2E98F544ADBQ35175922-616C1A59-923D-4687-BC8B-961665F85DEEQ35212126-9BC57D17-4C75-45A6-AAF8-F8131CEAB019Q35370804-38F33880-2720-4F35-8724-5C8B08236BA6Q35371115-2A9BE163-206F-41CB-BDD8-EE2AFC7F630BQ35424733-F5302651-88E3-4E94-8D8E-679A6F7ACFA2Q35782466-8103F90B-48C2-4A62-9D85-B161C9B8D2BDQ35810497-C52CACFC-30CF-4EB2-9004-0131D0CC2F0FQ35843765-41E7DA8F-D19A-4654-BBE8-F5B85F60CC8CQ35968929-0A416CD6-D116-42F4-BF96-D4E0E2B88D4AQ36010200-243BB24A-226A-4262-AB61-59167B5EC719Q36084269-2D8D5A1F-641E-4FCE-AA08-EC08316D6E0EQ36168570-8C9736D4-7936-4EC9-9D62-F1D752072A87Q36206941-2F519774-88BE-406B-9A66-0EAC0C9D69F8
P2860
The elusive gold standard. Future perspectives for HIV adherence assessment and intervention.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The elusive gold standard. Fut ...... e assessment and intervention.
@en
type
label
The elusive gold standard. Fut ...... e assessment and intervention.
@en
prefLabel
The elusive gold standard. Fut ...... e assessment and intervention.
@en
P1476
The elusive gold standard. Fut ...... e assessment and intervention.
@en
P2093
Margaret A Chesney
P304
P356
10.1097/01.QAI.0000243112.91293.26
P407
P478
43 Suppl 1
P577
2006-12-01T00:00:00Z